1)John EB, et al:Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed, ELSEVIER, Amsterdam, 2019
2)Benjamin JS, et al:Antibiotic treatment of common infections;More evidence to support shorter durations. Curr Opin Infect Dis 33:433-440, 2020
3)Louis BR:The Maxwell Finland lecture;For the duration-Rational antibiotic administration in an era of antimicrobial resistance and clostridium difficile. Clin Infect Dis 46:491-496, 2008
infections in adults and children;Executive summary. Clin Infect Dis 52:285-292, 2011
5)中谷 敏,他:感染性心内膜炎の予防と治療に関するガイドライン(2017年改訂版),日本循環器学会 https://www.j-circ.or.jp/old/guideline/pdf/JCS2017_nakatani_h.pdf(2020年12月閲覧)
bacteremia;A systematic review and meta-analysis. Clin Microbiol Infect 23:900-906, 2017
bacteremia. Clin Infect Dis 61:18-28, 2015
bacteremia. J Infect 72:544-553, 2016
9)Munehiro F, et al:Infectious diseases consultation improves treatment and decreases mortality by enterococcal bacteremia in children. Pediatr Infect Dis J 37:856-860, 2018
10)Rachael AL, et al:Infectious diseases consultation is associated with decreased mortality in enterococcal blood stream infections. Open Forum Infect Dis 7:ofaa064, 2020
11)Leonard AM, et al:Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection;2009 update by the infectious diseases society of America. CID 49:1-45, 2009
12)Emilio B, et al:The NOVA score;A proposal to reduce the need for transesophageal echocardiography in patients with Enterococcal bacteremia. Clin Infect Dis 60:528-535, 2015
13)Dafna Y, et al:Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia;A noninferiority randomized controlled trial. Clin Infect Dis 69:1091-1098, 2019
14)Darunee C, et.al:Comparing the outcomes of adults with Enterobacteriaceae bacteremia receiving short-course versus prolonged-course antibiotic therapy in a multicenter, propensity score-matched cohort. Clin Infect Dis 66:172-177, 2018
15)Avery NN, et al:Optimal duration 0f antimicrobial therapy for uncomplicated Gram-negative bloodstream infections. Infection 45:613-620, 2017
16)Elodie VD, et al:Effect of C-reactive protein-guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated gram-negative bacteremia;A randomized clinical trial. JAMA 323:2160-2169, 2020
17)Peter GP, et al:Clinical practice guidelines for the management of Candidiasis;2016 update by the infectious diseases society of America. Clin Infect Dis 62:e1-50, 2016
18)Louis B, et al :Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis;An open-label, non-inferiority, randomized, controlled trial. Lancet 385:875-882, 2015
19)Chung YH, et al:Short- versus long-course antibiotics in osteomyelitis;A systematic review and meta-analysis. Int J Antimicrobial Agents 53:246-260, 2019